Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 204S204 trades$51.20M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 19 |  Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | NETCloudflare, Inc. Open-market sale · 10b5-1 plan | SELL | $350K 1,665 sh |
| Apr 8, 2026 traded Apr 8, 2026 |
| 19 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | NETCloudflare, Inc. Open-market sale · 10b5-1 plan | SELL | $467K 2,227 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 19 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $273K 19.1K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 18 | Klimenko PaulinaCHIEF GROWTH OFFICER |  PUBMPubMatic, Inc.Open-market sale · 10b5-1 plan | SELL | $99K 11.8K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Tamari ShaharDirector, COO |  GLBEGlobal-E Online Ltd.Open-market sale · 10b5-1 plan | SELL | $260K 8,333 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Buckley MerileeCHIEF ACCOUNTING OFFICER |  ETSYETSY INCOpen-market sale · 10b5-1 plan | SELL | $6,586 122 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Griffith JesseChief Operations Officer |  RRGBRED ROBIN GOURMET BURGERS INCOpen-market sale | SELL | $3,053 1,008 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Buckley MerileeCHIEF ACCOUNTING OFFICER | ETSYETSY INC Open-market sale · 10b5-1 plan | SELL | $37K 687 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Camblong JurgiDirector, Chief Executive Officer |  SOPHSOPHiA GENETICS SAOpen-market sale · 10b5-1 plan | SELL | $12K 2,500 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | NETCloudflare, Inc. Open-market sale · 10b5-1 plan | SELL | $118K 567 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $13K 2,700 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Date Rajeev VDirector | CRCLCircle Internet Group, Inc. Open-market sale · 10b5-1 plan | SELL | $121K 1,273 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Camblong JurgiDirector, Chief Executive Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $13K 2,600 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $12K 2,400 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Van Well DaanChief Legal Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $12K 2,400 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Cardoza GeorgeChief Financial Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $12K 2,413 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Verma AbhimanyuChief Technology Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $5,016 1,030 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Doyle MittieChief Medical Officer |  AVTXAvalo Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $72K 3,970 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Valente ManuelaChief People Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $12K 2,376 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Date Rajeev VDirector | CRCLCircle Internet Group, Inc. Open-market sale · 10b5-1 plan | SELL | $237K 2,546 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Van Well DaanChief Legal Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $13K 2,705 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Cardoza GeorgeChief Financial Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $12K 2,520 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Valente ManuelaChief People Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $13K 2,597 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Menu PhilippeChief Medical Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $13K 2,700 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Menu PhilippeChief Medical Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $12K 2,400 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Muken RossPresident | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $13K 2,600 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Muken RossPresident | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $12K 2,424 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 13 | Yi StevenDirector, See Remarks | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 4,000 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 13 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $1,548 100 sh | Apr 8, 2026 traded Apr 8, 2026 |
| 13 | Yi StevenDirector, See Remarks | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $39K 4,000 sh | Apr 8, 2026 traded Apr 8, 2026 |
| 13 | Yi StevenDirector, See Remarks | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $38K 4,000 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 13 | Brown ShellyEVP, Chief Strategy Officer | MIAXMIAMI INTERNATIONAL HOLDINGS, INC. Open-market sale · 10b5-1 plan | SELL | $97K 2,357 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 12 | Desmond SeanDirector, CEO & President |  NCNOnCino, Inc.Open-market sale · 10b5-1 plan | SELL | $263K 15.4K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 12 | Moat RossCHIEF OPERATING OFFICER |  KNSAKiniksa Pharmaceuticals International, plcOpen-market sale · 10b5-1 plan | SELL | $115K 2,367 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 9 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $273K 5,200 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 9 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $515K 10.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 9 | Borgeson BlakeDirector |  RXRXRECURSION PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $93K 30.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 9 | Winkles IsabelleChief Financial Officer |  BRZEBraze, Inc.Open-market sale · 10b5-1 plan | SELL | $193K 8,274 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 8 | Cowan ElviaSVP, Finance & CAO |  PCVXVaxcyte, Inc.Open-market sale · 10b5-1 plan | SELL | $180K 3,000 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 6 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $198K 3,900 sh | Apr 8, 2026 traded Apr 7, 2026 |